설문조사를 통한 전문가 대상 예방접종 후 이상반응 관련 우선순위 연구주제 선정 기준모델 제시
Selecting the Priority Research Topics Addressing Unmet Post-immunization Safety Needs: A Model for Generating Research Proposal and Designing a Questionnaire for the Clinical Experts
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective: To gather inputs from clinical experts on selecting and prioritizing research topics, to address unmet vaccine safety needs. Methods: A questionnaire containing 15 vaccine safety assessment research proposals was sent to 28 vaccine experts chosen from various domestic medical association boards, and the rationale for each of the proposals was provided by presenting the following information: 1) a brief summary of the clinical safety studies on the vaccine, conducted by the Clinical Immunization Safety Assessment (CISA) project group, supervised by the United States Center for Disease Control (U.S. CDC), and 2) a summary of recently published studies that address vaccine safety issues. The experts were instructed to select and rank 5 topics in the order of preference, and the preference score for each proposed topic was calculated by assigning points on a scale of 1 to 5. Results: All 28 experts responded to the questionnaire, and the following topics were selected according to their calculated preference scores: 1) Human papillomavirus vaccine safety profile in the Korean female adolescents; 2) A signal detection of adverse events following Influenza vaccination: comparison between the US and South Korea; 3) Incidence of anaphylaxis following National Immunization Program vaccines between 2008 and 2017; 4) Safety of quadrivalent influenza vaccines compared to trivalent influenza vaccines; and 5) Pneumococcal vaccine safety profile in the general population. Conclusion: Five research topics addressing vaccine safety were selected, for which well-constructed research protocols need to be promptly developed to address current unmet vaccine safety needs in South Korea.
Abstract
Objective: To gather inputs from clinical experts on selecting and prioritizing research topics, to address unmet vaccine safety needs. Methods: A questionnaire containing 15 vaccine safety assessment research proposals was sent to 28 vaccine experts chosen from various domestic medical association boards, and the rationale for each of the proposals was provided by presenting the following information: 1) a brief summary of the clinical safety studies on the vaccine, conducted by the Clinical Immunization Safety Assessment (CISA) project group, supervised by the United States Center for Disease Control (U.S. CDC), and 2) a summary of recently published studies that address vaccine safety issues. The experts were instructed to select and rank 5 topics in the order of preference, and the preference score for each proposed topic was calculated by assigning points on a scale of 1 to 5. Results: All 28 experts responded to the questionnaire, and the following topics were selected according to their calculated preference scores: 1) Human papillomavirus vaccine safety profile in the Korean female adolescents; 2) A signal detection of adverse events following Influenza vaccination: comparison between the US and South Korea; 3) Incidence of anaphylaxis following National Immunization Program vaccines between 2008 and 2017; 4) Safety of quadrivalent influenza vaccines compared to trivalent influenza vaccines; and 5) Pneumococcal vaccine safety profile in the general population. Conclusion: Five research topics addressing vaccine safety were selected, for which well-constructed research protocols need to be promptly developed to address current unmet vaccine safety needs in South Korea.
참고문헌 (21)
- Zhou M, "Trust collapse caused by the Changsheng vaccine crisis in China", Vaccine, 26, pp.3419~3425 (2019)
- Spencer JP, "Vaccine adverse events: separating myth from reality", Am Fam Physician, 95(12), pp.786~794 (2017)
- Wormsbecker AE, "Demonstration of background rates of three conditions of interest for vaccine safety surveillance", PLoS One, 14(1), pp.e0210833~ (2019)
- "Vaccine Adverse Event Reporting System"[URL]
- "Vaccine Adverse Event Reporting System"[URL]
- "The Immunization Safety Office"[URL]
- "Vaccine Safety Monitoring"[URL]
- "Vaccine Safety Datalink"[URL]
- "Clinical Immunization Safety Assessment Project"[URL]
- "Clinical Immunization Safety Assessment Project Publications"[URL]
- LaRussa PS, "Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network", Pediatrics, 127(Suppl 1), pp.S65~S73 (2011)
- Kochhar S, "Introduction of new vaccines for immunization in: pregnancyprogrammatic, regulatory, safety and ethical considerations", Vaccine, 37(25), pp.3267~3277 (2019)
- Mathian A, "Lupus and vaccinations", Curr Opin Rheumatol, 30(5), pp.465~470 (2018)
- Murdaca G, "Influenza and pneumococcal vaccinations of patients with systemic lupus erythematosus: current views upon safety and immunogenicity", Autoimmun Rev, 13(2), pp.75~84 (2014)
- 오민정, "임신 중 예방접종", 대한의사협회지, 59(7), pp.523~528 (2016), 대한의사협회[DOI]
- Stockwell MS, "Feasibility of text message influenza vaccine safety monitoring during pregnancy", Am J Prev Med, 53(3), pp.282~289 (2017)
- Jacobson TA, "The statin adverse treatment experience survey: experience of patients reporting side effects of statin therapy", J Clin Lipidol, 13(3), pp.415~424 (2019)
- 손대은, "간이설문을 이용한 측두하악장애의 역학연구", Journal of Oral Medicine and Pain, 29(4), pp.341~351 (2004), 대한안면통증∙구강내과학회
- Stergiopoulos S, "A survey of adverse event reporting practices among US healthcare professionals", Drug Saf, 39(11), pp.1117~1127 (2016)
- Herrera Gomez A, "Safety and efficacy of influenza vaccine in pregnancy", Rev Enferm, 38(2), pp.38~41 (2015)
- "Pregnant women will also receive the influenza vaccine for ‘free’ from this year" (2019)[URL]